News & Updates

Stair climbing difficulty tied to higher death risk in adults with knee OA
Stair climbing difficulty tied to higher death risk in adults with knee OA
23 Apr 2024
Hyperglycaemia, dyslipidemia up risk of diabetic kidney disease
Hyperglycaemia, dyslipidemia up risk of diabetic kidney disease
23 Apr 2024

A recent study has identified six common metabolic profiles among patients with type 2 diabetes (T2D). In addition, severe hyperglycaemia and moderate dyslipidemia are associated with an increased risk of diabetic kidney disease (DKD).

Hyperglycaemia, dyslipidemia up risk of diabetic kidney disease
23 Apr 2024
VT ablation reduces ICD therapy, hospitalization for arrhythmia
VT ablation reduces ICD therapy, hospitalization for arrhythmia
23 Apr 2024 byAudrey Abella

Ablation of ventricular tachycardia (VT) before placement of an implantable cardioverter-defibrillator (ICD) is associated with a reduced risk of appropriate ICD therapy or ventricular arrhythmia (VA)-related hospitalization in patients with ischaemic cardiomyopathy (ICM) and chronic total occlusion of an infarct-related artery (IRA-CTO), findings from the PREVENTIVE VT trial have shown.

VT ablation reduces ICD therapy, hospitalization for arrhythmia
23 Apr 2024
Rapid response with a CDK4/6 inhibitor in an elderly patient with HR-positive, HER2-negative advanced breast cancer and comor
Rapid response with a CDK4/6 inhibitor in an elderly patient with HR-positive, HER2-negative advanced breast cancer and comorbidities
23 Apr 2024 byDr. Wendy Chan

The patient was a 70-year-old female who presented with a large, fungating left breast mass in September 2022. Although first symptoms were noticed approximately a year earlier, the patient did not seek consultation sooner for fear of cancer diagnosis. Upon examination, the mass occupied the entire left breast. The patient also suffered from shortness of breath and left breast pain. These symptoms worsened, resulting in hospitalization. 

Rapid response with a CDK4/6 inhibitor in an elderly patient with HR-positive, HER2-negative advanced breast cancer and comorbidities
23 Apr 2024